290 related articles for article (PubMed ID: 28917123)
1. Identification of new potent inhibitor of aldose reductase from Ocimum basilicum.
Bhatti HA; Tehseen Y; Maryam K; Uroos M; Siddiqui BS; Hameed A; Iqbal J
Bioorg Chem; 2017 Dec; 75():62-70. PubMed ID: 28917123
[TBL] [Abstract][Full Text] [Related]
2. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors.
Gopinath G; Sankeshi V; Perugu S; Alaparthi MD; Bandaru S; Pasala VK; Chittineni PR; Krupadanam GLD; Sagurthi SR
Eur J Med Chem; 2016 Nov; 124():750-762. PubMed ID: 27639366
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca.
Abdel Motaal A; El-Askary H; Crockett S; Kunert O; Sakr B; Shaker S; Grigore A; Albulescu R; Bauer R
Phytomedicine; 2015 Aug; 22(9):829-36. PubMed ID: 26220630
[TBL] [Abstract][Full Text] [Related]
5. 2″,4″-O-diacetylquercitrin, a novel advanced glycation end-product formation and aldose reductase inhibitor from Melastoma sanguineum.
Lee IS; Kim IS; Lee YM; Lee Y; Kim JH; Kim JS
Chem Pharm Bull (Tokyo); 2013; 61(6):662-5. PubMed ID: 23727780
[TBL] [Abstract][Full Text] [Related]
6. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
Metwally K; Pratsinis H; Kletsas D; Quattrini L; Coviello V; Motta C; El-Rashedy AA; Soliman ME
Future Med Chem; 2017 Dec; 9(18):2147-2166. PubMed ID: 29098865
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the inhibitory activity of Abeliophyllum distichum leaf constituents against aldose reductase by using high-speed counter current chromatography.
Li HM; Kim JK; Jang JM; Cui CB; Lim SS
Arch Pharm Res; 2013 Sep; 36(9):1104-12. PubMed ID: 23645536
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and activity of a new series of (Z)-3-phenyl-2-benzoylpropenoic acid derivatives as aldose reductase inhibitors.
Wang SJ; Yan JF; Hao D; Niu XW; Cheng MS
Molecules; 2007 Apr; 12(4):885-95. PubMed ID: 17851441
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vitro aldose reductase inhibitory potential of alkaloidal fractions of Piper nigrum, Murraya koenigii, Argemone mexicana, and Nelumbo nucifera.
Gupta S; Singh N; Jaggi AS
J Basic Clin Physiol Pharmacol; 2014 May; 25(2):255-65. PubMed ID: 24127538
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
Endo S; Hu D; Suyama M; Matsunaga T; Sugimoto K; Matsuya Y; El-Kabbani O; Kuwata K; Hara A; Kitade Y; Toyooka N
Bioorg Med Chem; 2013 Nov; 21(21):6378-84. PubMed ID: 24071447
[TBL] [Abstract][Full Text] [Related]
13. Novel 2-phenoxypyrido[3,2-
Hao X; Qi G; Ma H; Zhu C; Han Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1368-1372. PubMed ID: 31347930
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Hao X; Zhang S; Wang W; Qin X; Yang Y; Chen X; Zhu S; Zhu C; Ma B
Eur J Med Chem; 2014 Jun; 80():383-92. PubMed ID: 24793885
[TBL] [Abstract][Full Text] [Related]
15. Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors.
Saito R; Hoshi M; Kato A; Ishikawa C; Komatsu T
Eur J Med Chem; 2017 Jan; 125():965-974. PubMed ID: 27769036
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Aldose Reductase Inhibitory Activity of Botryllazine A Derivatives.
Saito R; Ishibashi K; Noumi M; Uno S; Higashi S; Goto M; Kuwahara S; Komatsu T
Chem Pharm Bull (Tokyo); 2019; 67(6):556-565. PubMed ID: 31155561
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
18. Exploration of thioxothiazolidinone-sulfonate conjugates as a new class of aldehyde/aldose reductase inhibitors: A synthetic and computational investigation.
Andleeb H; Tehseen Y; Jabeen F; Khan I; Iqbal J; Hameed S
Bioorg Chem; 2017 Dec; 75():1-15. PubMed ID: 28888096
[TBL] [Abstract][Full Text] [Related]
19. Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
Van Zandt MC; Doan B; Sawicki DR; Sredy J; Podjarny AD
Bioorg Med Chem Lett; 2009 Apr; 19(7):2006-8. PubMed ID: 19250825
[TBL] [Abstract][Full Text] [Related]
20. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng.
Fatmawati S; Ersam T; Yu H; Zhang C; Jin F; Shimizu K
Bioorg Med Chem Lett; 2014 Sep; 24(18):4407-4409. PubMed ID: 25152999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]